Return to homepagePandemic Pact

Novavax

  • Funded by Coalition for Epidemic Preparedness Innovations (CEPI)
  • Total publications:1000 publications

Grant number: N/A

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $4,000,000

  • Funder

    Coalition for Epidemic Preparedness Innovations (CEPI)

  • Principal Investigator

    Gregory Glenn

  • Research Location

    United States of America

  • Lead Research Institution

    Novavax

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Phase 1 clinical trial

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase I

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Antigen is recombinant full-length S protein nanoparticles engineered in baculovirus and expressed in Sf9 insect cells; Adjuvant is saponin-based Matrix-M (raw material sourced from tree bark from source in Chile)Phase I safety and immunogenicity

Publicationslinked via Europe PMC

Last Updated:4 hours ago

View all publications at Europe PMC

Nucleosome spacing can fine-tune higher-order chromatin assembly.

Inhibition of the minor spliceosome restricts the growth of a broad spectrum of cancers.

Environmental variability shapes the representational format of cultural learning.

The cytosolic branched-chain amino transferase 1 (BCAT1/BCATc) inhibitor reduces mitochondrial capacity in a myotube model of insulin resistance.

An aminosterol breaks the autocatalytic cycle of Aβ<sub>42</sub> aggregation and protects cell membranes from its soluble aggregates.

Directional sensitivity of the auriculomotor system to transient central and lateralized auditory stimuli.

Framework for bias evaluation in large language models in healthcare settings.

Trends and perspectives in deterministic MINLP optimization for integrated planning, scheduling, control, and design of chemical processes

Distinguishing PEX2 and PEX16 gene variant severity for mild, severe, and atypical peroxisome biogenesis disorders in Drosophila.